PainReform Ltd. (PRFX)
Automate Your Wheel Strategy on PRFX
With Tiblio's Option Bot, you can configure your own wheel strategy including PRFX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRFX
- Rev/Share 0.0
- Book/Share -0.5885
- PB -2.8888
- Debt/Equity -0.0289
- CurrentRatio 0.6117
- ROIC 9.5434
- MktCap 3422338.0
- FreeCF/Share -2.9226
- PFCF -0.3376
- PE -0.3329
- Debt/Assets 0.019
- DivYield 0
- ROE -7.54
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
Published: May 27, 2025 by: PRNewsWire
Sentiment: Neutral
As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel , May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).
Read More
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
Published: March 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation
Read More
About PainReform Ltd. (PRFX)
- IPO Date 2020-09-01
- Website https://www.painreform.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Dr. Ehud Geller Ph.D.
- Employees 2